HCAT
$1.17
Health Catalyst, Inc.
Intraday
Recent News
Health Catalyst (HCAT) Q4 2025 Earnings Transcript
Matt Hopper: Which ended 12/31/2025. My name is Matt Hopper, Senior Vice President of Finance and Head of Investor Relations. With me on the call today are Ben Albert, our Chief Executive Officer, and Jason Alger, our Chief Financial Officer.
Health Catalyst Inc (HCAT) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges and ...
Despite a dip in quarterly revenue, Health Catalyst Inc (HCAT) reports strong EBITDA growth and outlines strategic plans to enhance market alignment and operational efficiency.
Health Catalyst Q4 Earnings Call Highlights
Health Catalyst (NASDAQ:HCAT) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline a leadership transition, discuss the financial impact of continued restructuring and platform migrations, and preview changes to how the company will communicate performance metrics
Health Catalyst (HCAT) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Health Catalyst (HCAT) Lags Q4 Earnings Estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of -14.26% and +1.45%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?